Albert David Faces Significant Volatility Amid Broader Market Resilience
Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, reflecting significant volatility and underperformance compared to its sector. The company has faced challenges, including a decline in operating profit and low net sales, contributing to a negative performance over the past year.
Albert David, a microcap player in the Pharmaceuticals & Drugs industry, has experienced significant volatility today, hitting a new 52-week low of Rs. 773.3. This decline marks a notable underperformance, with the stock down 10.63% over the past two days and trailing the sector by 2.96%. The stock opened with a gap down of 4.9% and reached an intraday low of Rs. 773.3, reflecting a bearish trend as it trades below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.In the broader market context, the Sensex has shown resilience, recovering from an initial drop of 3,914.75 points to currently trade at 72,776.96, although it remains 3.49% away from its own 52-week low. Over the past year, Albert David's performance has been starkly negative, with a decline of 34.86%, contrasting sharply with the Sensex's drop of only 2.01%.
Financially, the company has faced challenges, including a significant decrease in operating profit and a net sales figure of Rs. 83.08 crore, the lowest recorded. Despite a low debt-to-equity ratio and an attractive valuation with a return on equity of 10.6, the stock's technical indicators suggest a bearish outlook, reflecting ongoing struggles in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
